In the setting of CTCL, TSLP can stimulate CD4+ T cells to express IL-4 and IL-13 both directly, through TSLP receptors on these cells [27], and indirectly, through dendritic cells [75]. Here, IL4 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.